Technology to enable the specialty patient journey is becoming IT's problem, but the fix isn't becoming the expert.
Specialty pharma has an infrastructure problem, and IT can’t solve it alone
Specialty pharma has an infrastructure problem, and IT can’t solve it alone is a pharma and life sciences industry update from PharmaVoice. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: PharmaVoice